Antiphospholipid antibodies activity may help explain hypercoagulation associated with late stages of Covid-19 and long-haul disease. Blood samples from nearly 250 individuals hospitalized for Covid-19 found that these “rouge” antibodies activate endothelial cells, risking widespread blood clots.
Subscribe to:
Post Comments (Atom)
< + > Stop Waiting on Mandates: CMS Challenges Health IT to Act Now
“We’re the government and we’re here to help.” That’s a common punchline, but based on recent IT announcements from CMS, this line may turn ...
No comments:
Post a Comment